4.7 Article

Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood

Yue-Ting Deng et al.

Summary: In this study, the researchers integrated brain and blood protein and expression quantitative trait loci (QTL) data with a depression GWAS dataset using statistical analyses including Mendelian randomization, Bayesian colocalization, and Steiger filtering. They identified several candidate genes for depression and also discovered insights into the interaction between brain and blood in depression through protein-protein interaction (PPI) network analysis.

MOLECULAR PSYCHIATRY (2022)

Review Medical Laboratory Technology

Effects of fetuin-A with diverse functions and multiple mechanisms on human health

Mehmet Arif Icer et al.

Summary: Fetuin-A is a glycoprotein mainly synthesized by hepatocytes and released into the bloodstream, with inhibitory and stimulatory effects on health through various mechanisms such as inflammatory cytokines regulation.

CLINICAL BIOCHEMISTRY (2021)

Article Genetics & Heredity

Large-scale integration of the plasma proteome with genetics and disease

Egil Ferkingstad et al.

Summary: Genome-wide association studies of plasma protein levels in Icelanders have identified numerous associations with diseases and other traits, providing valuable insights into disease pathogenesis and potential drug targets. Through integration of proteomics, genomics, and transcriptomics, this research offers a resource for improving disease understanding and aiding drug discovery and development.

NATURE GENETICS (2021)

Review Medicine, General & Internal

Diagnosis and Treatment of Multiple Sclerosis A Review

Marisa P. McGinley et al.

Summary: Multiple sclerosis is a neurodegenerative disease that affects the central nervous system, leading to physical disability, cognitive impairment and decreased quality of life. Current disease-modifying therapies can reduce relapse rates by 29% to 68% compared to placebo or active comparators.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Multidisciplinary Sciences

Specific hypomethylation programs underpin B cell activation in early multiple sclerosis

Qin Ma et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Genetics & Heredity

Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis

Aliza P. Wingo et al.

Summary: This study identified 11 genes that may play a role in Alzheimer's disease (AD) by affecting brain protein abundance, through a proteome-wide association study. Eight of these genes are new AD risk genes not identified before by AD GWAS, providing new insights into AD pathogenesis. This research offers promising targets for further mechanistic and therapeutic studies on AD.

NATURE GENETICS (2021)

Article Multidisciplinary Sciences

Mapping the proteo-genomic convergence of human diseases

Maik Pietzner et al.

Summary: The study identified genetic associations for plasma proteins and established a map connecting genes, proteins, and diseases, highlighting biological convergence across diseases. This proteo-genomic map helps to understand relationships between diseases and provide biological context for emerging disorders.

SCIENCE (2021)

Article Neurosciences

Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders

Chengran Yang et al.

Summary: Yang et al. created a genomic atlas of protein levels in brain, cerebrospinal fluid, and plasma, identifying proteins linked to neurological diseases and potential drug targets. They found tissue-specific differences in protein quantitative trait loci (pQTLs) and observed that some pQTLs did not co-localize with other genetic regulation markers. This multi-tissue study could help map signals from genome-wide association studies to functional genes and discover drug targets for neurological diseases.

NATURE NEUROSCIENCE (2021)

Review Genetics & Heredity

Advancing the use of genome-wide association studies for drug repurposing

William R. Reay et al.

Summary: Genome-wide association studies have provided important biological insights into complex diseases, offering opportunities for drug repurposing. Leveraging common variant genetics through approaches such as single-loci mapping to drug targets, transcriptome-wide association studies, gene-set association, causal inference by Mendelian randomization, and polygenic scoring, researchers aim to identify new treatment options more efficiently.

NATURE REVIEWS GENETICS (2021)

Article Clinical Neurology

Prediction of long-term disability in Chinese patients with multiple sclerosis: A prospective cohort study

Yao Zhang et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Article Biochemical Research Methods

PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations

Mihir A. Kamat et al.

BIOINFORMATICS (2019)

Review Biotechnology & Applied Microbiology

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies

Simon Faissner et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Multidisciplinary Sciences

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

Nikolas A. Patsopoulos et al.

SCIENCE (2019)

Review Clinical Neurology

Multiple sclerosis - a review

R. Dobson et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

Review Biochemistry & Molecular Biology

Diagnosis and Management of Progressive Multiple Sclerosis

Gabrielle Macaron et al.

BIOMEDICINES (2019)

Article Biochemistry & Molecular Biology

DrugBank 5.0: a major update to the DrugBank database for 2018

David S. Wishart et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Clinical Neurology

Cladribine: mechanisms and mysteries in multiple sclerosis

Benjamin Meir Jacobs et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Article Cardiac & Cardiovascular Systems

Thymidine phosphorylase: A potential new target for treating cardiovascular disease

Wei Li et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2018)

Article Multidisciplinary Sciences

Genomic atlas of the human plasma proteome

Benjamin B. Sun et al.

NATURE (2018)

Article Multidisciplinary Sciences

Co-regulatory networks of human serum proteins link genetics to disease

Valur Emilsson et al.

SCIENCE (2018)

Article Multidisciplinary Sciences

Connecting genetic risk to disease end points through the human blood plasma proteome

Karsten Suhre et al.

NATURE COMMUNICATIONS (2017)

Article Genetics & Heredity

Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease

Lasse Folkersen et al.

PLOS GENETICS (2017)

Article Pharmacology & Pharmacy

Elotuzumab: First Global Approval

Anthony Markham

DRUGS (2016)

Article Clinical Neurology

Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease

Ya Zhang et al.

NEUROLOGICAL SCIENCES (2016)

Article Genetics & Heredity

The support of human genetic evidence for approved drug indications

Matthew R. Nelson et al.

NATURE GENETICS (2015)

Article Biochemistry & Molecular Biology

Mendelian randomization: genetic anchors for causal inference in epidemiological studies

George Davey Smith et al.

HUMAN MOLECULAR GENETICS (2014)

Article Immunology

FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation

Fu Jun Li et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2013)

Article Clinical Neurology

Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis

Violaine K. Harris et al.

MULTIPLE SCLEROSIS JOURNAL (2013)

Review Genetics & Heredity

From expression QTLs to personalized transcriptomics

Stephen B. Montgomery et al.

NATURE REVIEWS GENETICS (2011)

Article Biochemical Research Methods

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

Jan Ottervald et al.

JOURNAL OF PROTEOMICS (2010)

Article Neurosciences

Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis

Violaine K. Harris et al.

NEUROBIOLOGY OF DISEASE (2010)

Review Endocrinology & Metabolism

Type 1 diabetes mellitus and multiple sclerosis: common etiological features

Adam E. Handel et al.

NATURE REVIEWS ENDOCRINOLOGY (2009)

Article Multidisciplinary Sciences

VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

Azeb Tadesse Argaw et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)